Literature DB >> 31304568

Towards a Better Classification and Novel Therapies Based on the Genetics of Systemic Sclerosis.

Marialbert Acosta-Herrera1, Elena López-Isac2, Javier Martín3.   

Abstract

PURPOSE OF THE REVIEW: Nowadays, important advances have occurred in our understanding of the pathogenesis of systemic sclerosis (SSc), which is a rare immune-mediated inflammatory disease (IMID) characterized by vascular damage, immune imbalance, and fibrosis. Its etiology remains unknown; nevertheless, both environmental and genetic factors play a major role in the disease. This review will focus on the main advances made in the field of genetics of SSc. RECENT
FINDINGS: The assessment of how interindividual genetic variability affects disease onset and progression has enhanced our knowledge of disease biology, and this will eventually translate in the development of new diagnostic and therapeutic tools, which is the final goal of personalized medicine. We will provide an overview of the most relevant achievements in the genetics of SSc, its shared genetics among IMIDs with special attention on drug repurposing, current challenges for the functional characterization of risk variants, and future directions.

Entities:  

Keywords:  Drug reposition; Genetic risk factors; Genomic medicine; Scleroderma; Susceptibility loci

Year:  2019        PMID: 31304568     DOI: 10.1007/s11926-019-0845-6

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  48 in total

Review 1.  The pathogenesis of systemic sclerosis.

Authors:  Tamiko R Katsumoto; Michael L Whitfield; M Kari Connolly
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

Review 2.  Scleroderma.

Authors:  Armando Gabrielli; Enrico V Avvedimento; Thomas Krieg
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

3.  Association of HLA class II genes with systemic sclerosis in Spanish patients.

Authors:  Carmen P Simeón; Vicent Fonollosa; Carles Tolosa; Eduard Palou; Albert Selva; Roser Solans; Lluis Armadans; Estefania Moreno; Sara Marsal; Miquel Vilardell
Journal:  J Rheumatol       Date:  2009-11-02       Impact factor: 4.666

4.  Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.

Authors:  Timothy R D J Radstake; Olga Gorlova; Blanca Rueda; Jose-Ezequiel Martin; Behrooz Z Alizadeh; Rogelio Palomino-Morales; Marieke J Coenen; Madelon C Vonk; Alexandre E Voskuyl; Annemie J Schuerwegh; Jasper C Broen; Piet L C M van Riel; Ruben van 't Slot; Annet Italiaander; Roel A Ophoff; Gabriela Riemekasten; Nico Hunzelmann; Carmen P Simeon; Norberto Ortego-Centeno; Miguel A González-Gay; María F González-Escribano; Paolo Airo; Jaap van Laar; Ariane Herrick; Jane Worthington; Roger Hesselstrand; Vanessa Smith; Filip de Keyser; Fredric Houssiau; Meng May Chee; Rajan Madhok; Paul Shiels; Rene Westhovens; Alexander Kreuter; Hans Kiener; Elfride de Baere; Torsten Witte; Leonid Padykov; Lars Klareskog; Lorenzo Beretta; Rafaella Scorza; Benedicte A Lie; Anna-Maria Hoffmann-Vold; Patricia Carreira; John Varga; Monique Hinchcliff; Peter K Gregersen; Annette T Lee; Jun Ying; Younghun Han; Shih-Feng Weng; Christopher I Amos; Fredrick M Wigley; Laura Hummers; J Lee Nelson; Sandeep K Agarwal; Shervin Assassi; Pravitt Gourh; Filemon K Tan; Bobby P C Koeleman; Frank C Arnett; Javier Martin; Maureen D Mayes
Journal:  Nat Genet       Date:  2010-04-11       Impact factor: 38.330

5.  Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts.

Authors:  F C Arnett; M Cho; S Chatterjee; M B Aguilar; J D Reveille; M D Mayes
Journal:  Arthritis Rheum       Date:  2001-06

Review 6.  The transcriptional interactome: gene expression in 3D.

Authors:  Stefan Schoenfelder; Ieuan Clay; Peter Fraser
Journal:  Curr Opin Genet Dev       Date:  2010-03-06       Impact factor: 5.578

7.  HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans.

Authors:  Xiaodong Zhou; Jong Eun Lee; Frank C Arnett; Momiao Xiong; Min Young Park; Yeon Kyeong Yoo; Eun Soon Shin; John D Reveille; Maureen D Mayes; Jin Hyun Kim; Ran Song; Ji Yong Choi; Ji Ah Park; Yun Jong Lee; Eun Young Lee; Yeong Wook Song; Eun Bong Lee
Journal:  Arthritis Rheum       Date:  2009-12

8.  Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies.

Authors:  Carol Feghali-Bostwick; Thomas A Medsger; Timothy M Wright
Journal:  Arthritis Rheum       Date:  2003-07

9.  Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.

Authors:  Frank C Arnett; Pravitt Gourh; Sanjay Shete; Chul W Ahn; Robert E Honey; Sandeep K Agarwal; Filemon K Tan; Terry McNearney; Michael Fischbach; Marvin J Fritzler; Maureen D Mayes; John D Reveille
Journal:  Ann Rheum Dis       Date:  2009-07-12       Impact factor: 19.103

10.  Clinical, immunologic, and genetic features of familial systemic sclerosis.

Authors:  Shervin Assassi; Frank C Arnett; John D Reveille; Pravitt Gourh; Maureen D Mayes
Journal:  Arthritis Rheum       Date:  2007-06
View more
  1 in total

1.  Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci.

Authors:  Tianlu Li; Lourdes Ortiz-Fernández; Eduardo Andrés-León; Laura Ciudad; Biola M Javierre; Elena López-Isac; Alfredo Guillén-Del-Castillo; Carmen Pilar Simeón-Aznar; Esteban Ballestar; Javier Martin
Journal:  Genome Med       Date:  2020-09-25       Impact factor: 11.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.